NCS Multistage Holdings, Inc. Announces Second Quarter 2023 Results
Second Quarter Results
- Total revenues of
$25.4 million , an 8% year-over-year decrease - Net loss of
$(32.2) million and loss per share of$(13.02) , compared to a net loss of$(5.5) million and a loss per share of$(2.25) in the same quarter of 2022 - Adjusted net loss of
$(6.2) million and adjusted loss per share of$(2.50) , compared to an adjusted net loss of$(5.1) million and adjusted loss per share of$(2.09) - Adjusted EBITDA of
$(2.2) million , a decrease of$(0.3) million from the second quarter of 2022 $13.7 million in cash and$8.8 million of total debt as ofJune 30, 2023
Financial Review
Total revenues were
Compared to the first quarter of 2023, total revenues decreased by 42%, with decreases of 53% and 17% in
Gross profit, defined as total revenues less total cost of sales exclusive of depreciation and amortization, for the second quarter of 2023 was
Despite the declines in our second quarter and sequential revenues, our revenues for the first half of 2023 of
Selling, general and administrative (“SG&A”) expenses totaled
Net loss was
Our adjusted net loss was $(6.2) million, or
Adjusted EBITDA was
Cash flow from operating activities for the six months ended
Liquidity and Capital Expenditures
As of
NCS incurred capital expenditures, net of proceeds from the sale of property and equipment, of
Review and Outlook
NCS’s Chief Executive Officer,
Unfortunately, this was more than offset by challenges faced in the
Our total revenues of
Our second quarter gross margin percentage of 33% was in line with the second quarter of 2022, despite lower revenues, and increased to 39% for the first half of 2023 as compared to 36% for the first half of 2022. The favorable gross margin percentage primarily reflects initiatives to improve our pricing over the last two years.
We continuously assess opportunities to streamline our operations and improve profitability. We initiated efforts in
On our previously disclosed legal matter in
Given the rapid decline in the
I am encouraged about the opportunities for NCS in 2023 and beyond as we deliver on our long-term strategies to build upon our leading market positions, capitalize on opportunities in international and offshore markets and as we bring new and innovative solutions to our customers around the world.
I want to express my gratitude to the team at NCS and at Repeat Precision – it is through the expertise, dedication and ingenuity of our outstanding people that we can deliver extraordinary outcomes to our customers, drive innovation in the industry and create value for our shareholders.”
Adjusted EBITDA, Adjusted EBITDA margin, Adjusted EBITDA Less Share-Based Compensation, Adjusted Net (Loss) Income, Adjusted (Loss) Earnings per Diluted Share, Free Cash Flow, Free Cash Flow Less Distributions to Non-Controlling Interest and net working capital are non-GAAP financial measures. For an explanation of these measures and a reconciliation, refer to “Non-GAAP Financial Measures” below.
Conference Call
The Company will host a conference call to discuss its second quarter 2023 results and updated guidance on
The replay will be available in the Investors section of the Company’s website shortly after the conclusion of the call and will remain available for approximately seven days.
About
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,” “expects” and similar references to future periods, or by the inclusion of forecasts or projections. Examples of forward-looking statements include, but are not limited to, statements we make regarding the outlook for our future business and financial performance and insurance coverage and appellate prospects for litigation matters. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, our actual results may differ materially from those contemplated by the forward-looking statements. Important factors that could cause our actual results to differ materially from those in the forward-looking statements include regional, national or global political, economic, business, competitive, market and regulatory conditions and the following: declines in the level of oil and natural gas exploration and production activity in
Contact
Chief Financial Officer
(281) 453-2222
IR@ncsmultistage.com
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) (Unaudited) |
||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Revenues | ||||||||||||||||
Product sales | $ | 17,433 | $ | 19,371 | $ | 48,863 | $ | 45,584 | ||||||||
Services | 7,958 | 8,093 | 20,082 | 20,992 | ||||||||||||
Total revenues | 25,391 | 27,464 | 68,945 | 66,576 | ||||||||||||
Cost of sales | ||||||||||||||||
Cost of product sales, exclusive of depreciation and amortization expense shown below |
11,994 | 13,399 | 30,827 | 31,156 | ||||||||||||
Cost of services, exclusive of depreciation and amortization expense shown below |
4,935 | 5,124 | 11,115 | 11,570 | ||||||||||||
Total cost of sales, exclusive of depreciation and amortization expense shown below |
16,929 | 18,523 | 41,942 | 42,726 | ||||||||||||
Selling, general and administrative expenses | 14,477 | 13,745 | 30,628 | 29,769 | ||||||||||||
Depreciation | 948 | 939 | 1,891 | 1,860 | ||||||||||||
Amortization | 167 | 167 | 334 | 334 | ||||||||||||
Loss from operations | (7,130 | ) | (5,910 | ) | (5,850 | ) | (8,113 | ) | ||||||||
Other income (expense) | ||||||||||||||||
Interest expense, net | (211 | ) | (407 | ) | (420 | ) | (590 | ) | ||||||||
Provision for litigation | (24,886 | ) | — | (42,400 | ) | — | ||||||||||
Other income, net | 1,478 | 613 | 1,770 | 992 | ||||||||||||
Foreign currency exchange gain (loss), net | 23 | (255 | ) | 78 | 1 | |||||||||||
Total other (expense) income | (23,596 | ) | (49 | ) | (40,972 | ) | 403 | |||||||||
Loss before income tax | (30,726 | ) | (5,959 | ) | (46,822 | ) | (7,710 | ) | ||||||||
Income tax expense (benefit) | 1,350 | (481 | ) | 250 | (503 | ) | ||||||||||
Net loss | (32,076 | ) | (5,478 | ) | (47,072 | ) | (7,207 | ) | ||||||||
Net income (loss) attributable to non-controlling interest | 155 | 3 | 128 | (191 | ) | |||||||||||
Net loss attributable to |
$ | (32,231 | ) | $ | (5,481 | ) | $ | (47,200 | ) | $ | (7,016 | ) | ||||
Loss per common share | ||||||||||||||||
Basic loss per common share attributable to |
$ | (13.02 | ) | $ | (2.25 | ) | $ | (19.16 | ) | $ | (2.89 | ) | ||||
Diluted loss per common share attributable to |
$ | (13.02 | ) | $ | (2.25 | ) | $ | (19.16 | ) | $ | (2.89 | ) | ||||
Weighted average common shares outstanding | ||||||||||||||||
Basic | 2,476 | 2,438 | 2,464 | 2,426 | ||||||||||||
Diluted | 2,476 | 2,438 | 2,464 | 2,426 |
CONDENSED CONSOLIDATED BALANCE SHEETS* (In thousands, except share data) (Unaudited) |
||||||||
2023 | 2022 | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 13,746 | $ | 16,234 | ||||
Accounts receivable—trade, net | 22,169 | 27,846 | ||||||
Inventories, net | 42,788 | 37,042 | ||||||
Prepaid expenses and other current assets | 2,918 | 2,815 | ||||||
Other current receivables | 3,682 | 3,726 | ||||||
Total current assets | 85,303 | 87,663 | ||||||
Noncurrent assets | ||||||||
Property and equipment, net | 24,106 | 23,316 | ||||||
15,222 | 15,222 | |||||||
Identifiable intangibles, net | 4,741 | 5,076 | ||||||
Operating lease assets | 5,552 | 4,515 | ||||||
Deposits and other assets | 2,217 | 2,761 | ||||||
Deferred income taxes, net | 334 | 46 | ||||||
Total noncurrent assets | 52,172 | 50,936 | ||||||
Total assets | $ | 137,475 | $ | 138,599 | ||||
Liabilities and Stockholders’ Equity | ||||||||
Current liabilities | ||||||||
Accounts payable—trade | $ | 7,855 | $ | 7,549 | ||||
Accrued expenses | 4,423 | 4,391 | ||||||
Income taxes payable | 314 | 468 | ||||||
Operating lease liabilities | 1,578 | 1,274 | ||||||
Current maturities of long-term debt | 2,350 | 1,489 | ||||||
Other current liabilities | 1,670 | 2,522 | ||||||
Total current liabilities | 18,190 | 17,693 | ||||||
Noncurrent liabilities | ||||||||
Long-term debt, less current maturities | 6,404 | 6,437 | ||||||
Operating lease liabilities, long-term | 4,571 | 3,680 | ||||||
Accrual for legal contingencies | 42,400 | — | ||||||
Other long-term liabilities | 1,258 | 1,328 | ||||||
Deferred income taxes, net | 426 | 199 | ||||||
Total noncurrent liabilities | 55,059 | 11,644 | ||||||
Total liabilities | 73,249 | 29,337 | ||||||
Commitments and contingencies | ||||||||
Stockholders’ equity | ||||||||
Preferred stock, |
||||||||
— | — | |||||||
Common stock, |
||||||||
and 2,438,877 shares outstanding at |
||||||||
and 2,408,474 shares outstanding at |
25 | 24 | ||||||
Additional paid-in capital | 442,431 | 440,475 | ||||||
Accumulated other comprehensive loss | (85,274 | ) | (85,617 | ) | ||||
Retained deficit | (309,664 | ) | (262,464 | ) | ||||
at |
(1,653 | ) | (1,389 | ) | ||||
Total stockholders' equity | 45,865 | 91,029 | ||||||
Non-controlling interest | 18,361 | 18,233 | ||||||
Total equity | 64,226 | 109,262 | ||||||
Total liabilities and stockholders' equity | $ | 137,475 | $ | 138,599 |
_____________________
* Preliminary
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (Unaudited) |
||||||||
Six Months Ended | ||||||||
2023 | 2022 | |||||||
Cash flows from operating activities | ||||||||
Net loss | $ | (47,072 | ) | $ | (7,207 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | 2,225 | 2,194 | ||||||
Amortization of deferred loan costs | 102 | 128 | ||||||
Write-off of deferred loan costs | — | 196 | ||||||
Share-based compensation | 2,542 | 3,485 | ||||||
Provision for inventory obsolescence | 245 | 1,294 | ||||||
Deferred income tax expense | 57 | 59 | ||||||
Gain on sale of property and equipment | (333 | ) | (222 | ) | ||||
Provision for credit losses | 58 | (44 | ) | |||||
Provision for litigation | 42,400 | — | ||||||
Proceeds from note receivable | 271 | 282 | ||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable—trade | 6,474 | 3,878 | ||||||
Inventories, net | (5,907 | ) | (4,876 | ) | ||||
Prepaid expenses and other assets | 552 | 1,271 | ||||||
Accounts payable—trade | (196 | ) | 499 | |||||
Accrued expenses | (4 | ) | (2,767 | ) | ||||
Other liabilities | (2,331 | ) | (2,591 | ) | ||||
Income taxes receivable/payable | (125 | ) | (777 | ) | ||||
Net cash used in operating activities | (1,042 | ) | (5,198 | ) | ||||
Cash flows from investing activities | ||||||||
Purchases of property and equipment | (1,151 | ) | (420 | ) | ||||
Purchase and development of software and technology | (167 | ) | (56 | ) | ||||
Proceeds from sales of property and equipment | 340 | 175 | ||||||
Net cash used in investing activities | (978 | ) | (301 | ) | ||||
Cash flows from financing activities | ||||||||
Payments on finance leases | (743 | ) | (712 | ) | ||||
Line of credit borrowings | 8,397 | 7,543 | ||||||
Payments of line of credit borrowings | (7,663 | ) | (7,096 | ) | ||||
(264 | ) | (380 | ) | |||||
Payment of deferred loan cost related to ABL facility | — | (880 | ) | |||||
Net cash used in financing activities | (273 | ) | (1,525 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents | (195 | ) | (214 | ) | ||||
Net change in cash and cash equivalents | (2,488 | ) | (7,238 | ) | ||||
Cash and cash equivalents beginning of period | 16,234 | 22,168 | ||||||
Cash and cash equivalents end of period | $ | 13,746 | $ | 14,930 | ||||
Noncash investing and financing activities | ||||||||
Assets obtained in exchange for new finance lease liabilities | $ | 845 | $ | 864 | ||||
Assets obtained in exchange for new operating lease liabilities | $ | 1,789 | $ | 819 |
REVENUES BY GEOGRAPHIC AREA (In thousands) (Unaudited) |
||||||||||||
Three Months Ended | Six Months Ended | |||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||
Product sales | $ | 6,942 | $ | 9,173 | $ | 15,002 | $ | 16,334 | ||||
Services | 2,440 | 2,960 | 5,699 | 4,877 | ||||||||
Total |
9,382 | 12,133 | 20,701 | 21,211 | ||||||||
Product sales | 9,970 | 9,655 | 32,531 | 28,707 | ||||||||
Services | 4,351 | 3,193 | 12,461 | 12,670 | ||||||||
Total |
14,321 | 12,848 | 44,992 | 41,377 | ||||||||
Other Countries | ||||||||||||
Product sales | 521 | 543 | 1,330 | 543 | ||||||||
Services | 1,167 | 1,940 | 1,922 | 3,445 | ||||||||
Total Other Countries | 1,688 | 2,483 | 3,252 | 3,988 | ||||||||
Total | ||||||||||||
Product sales | 17,433 | 19,371 | 48,863 | 45,584 | ||||||||
Services | 7,958 | 8,093 | 20,082 | 20,992 | ||||||||
Total revenues | $ | 25,391 | $ | 27,464 | $ | 68,945 | $ | 66,576 |
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands, except per share data)
(Unaudited)
Non-GAAP Financial Measures
EBITDA is defined as net (loss) income before interest expense, net, income tax expense and depreciation and amortization. Adjusted EBITDA is defined as EBITDA adjusted to exclude certain items which we believe are not reflective of ongoing operating performance or which, in the case of share-based compensation, is non-cash in nature. Adjusted EBITDA margin represents Adjusted EBITDA as a percentage of total revenues. Adjusted EBITDA Less Share-Based Compensation is defined as Adjusted EBITDA minus share-based compensation expense. Adjusted Net (Loss) Income is defined as net (loss) income attributable to
EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted EBITDA Less Share-Based Compensation, Adjusted Net (Loss) Income, Adjusted (Loss) Earnings per Diluted Share, Free Cash Flow, Free Cash Flow Less Distributions to Non-Controlling Interest and net working capital (our “non-GAAP financial measures”) are not defined under generally accepted accounting principles (“GAAP”), are not measures of net (loss) income, (loss) income from operations, cash (used in) provided by operating activities, working capital or any other performance measure derived in accordance with GAAP, and are subject to important limitations. Our non-GAAP financial measures may not be comparable to similarly titled measures of other companies in our industry and are not measures of performance calculated in accordance with GAAP. Our non-GAAP financial measures have important limitations as analytical tools and you should not consider them in isolation or as substitutes for analysis of our financial performance as reported under GAAP, and they should not be considered as alternatives to net (loss) income, (loss) income from operations, cash (used in) provided by operating activities, working capital or any other performance measures derived in accordance with GAAP as measures of operating performance or as alternatives to cash flow from operating activities as measures of our liquidity.
The tables below set forth reconciliations of our non-GAAP financial measures to the most directly comparable measures of financial performance calculated under GAAP:
NET WORKING CAPITAL* | ||||||||
2023 | 2022 | |||||||
Working capital | $ | 67,113 | $ | 69,970 | ||||
Cash and cash equivalents | (13,746 | ) | (16,234 | ) | ||||
Current maturities of long term debt | 2,350 | 1,489 | ||||||
Net working capital | $ | 55,717 | $ | 55,225 |
_____________________
* Preliminary
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION (In thousands, except per share data) (Unaudited) |
||||||||||||||||||||||||||||||||
ADJUSTED NET LOSS AND ADJUSTED LOSS PER DILUTED SHARE | ||||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||||
Effect on Net Loss |
Impact on Diluted Loss Per Share |
Effect on Net Loss |
Impact on Diluted Loss Per Share |
Effect on Net Loss |
Impact on Diluted Loss Per Share |
Effect on Net Loss |
Impact on Diluted Loss Per Share |
|||||||||||||||||||||||||
Net loss attributable to |
$ | (32,231 | ) | $ | (13.02 | ) | $ | (5,481 | ) | $ | (2.25 | ) | $ | (47,200 | ) | $ | (19.16 | ) | $ | (7,016 | ) | $ | (2.89 | ) | ||||||||
Adjustments | ||||||||||||||||||||||||||||||||
Provision for litigation (a) | 24,886 | 10.05 | — | — | 42,400 | 17.21 | — | — | ||||||||||||||||||||||||
Foreign currency exchange (gain) loss (b) | (48 | ) | (0.02 | ) | 232 | 0.09 | (105 | ) | (0.04 | ) | (17 | ) | (0.01 | ) | ||||||||||||||||||
Write-off of deferred loan costs (c) |
— | — | 196 | 0.08 | — | — | 196 | 0.08 | ||||||||||||||||||||||||
Income tax impact from adjustments (d) | 1,197 | 0.49 | (32 | ) | (0.01 | ) | 288 | 0.12 | (15 | ) | — | |||||||||||||||||||||
Adjusted net loss attributable to |
$ | (6,196 | ) | $ | (2.50 | ) | $ | (5,085 | ) | $ | (2.09 | ) | $ | (4,617 | ) | $ | (1.87 | ) | $ | (6,852 | ) | $ | (2.82 | ) |
__________________
(a) Represents litigation provision associated with certain litigation matters. We intend to appeal the judgment awarded in
(b) Represents realized and unrealized foreign currency translation gains and losses attributable to
(c) Represents deferred loan costs of
(d) Represents income tax impacts based on applicable effective tax rates. The 2022 amounts were changed from prior presentation to exclude the effect of valuation allowance adjustments.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION (In thousands) (Unaudited) |
||||||||||||||||
ADJUSTED EBITDA, ADJUSTED EBITDA MARGIN, AND ADJUSTED EBITDA LESS SHARE-BASED COMPENSATION | ||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Net loss | $ | (32,076 | ) | $ | (5,478 | ) | $ | (47,072 | ) | $ | (7,207 | ) | ||||
Income tax expense (benefit) | 1,350 | (481 | ) | 250 | (503 | ) | ||||||||||
Interest expense, net | 211 | 407 | 420 | 590 | ||||||||||||
Depreciation | 948 | 939 | 1,891 | 1,860 | ||||||||||||
Amortization | 167 | 167 | 334 | 334 | ||||||||||||
EBITDA | (29,400 | ) | (4,446 | ) | (44,177 | ) | (4,926 | ) | ||||||||
Provision for litigation (a) | 24,886 | — | 42,400 | — | ||||||||||||
Share-based compensation (b) | 1,044 | 841 | 1,957 | 1,646 | ||||||||||||
Professional fees (c) | 577 | 1,078 | 1,661 | 3,145 | ||||||||||||
Foreign currency exchange (gain) loss (d) | (23 | ) | 255 | (78 | ) | (1 | ) | |||||||||
Severance and other termination benefits (e) | 309 | — | 309 | — | ||||||||||||
Other (f) | 362 | 277 | 553 | 422 | ||||||||||||
Adjusted EBITDA | $ | (2,245 | ) | $ | (1,995 | ) | $ | 2,625 | $ | 286 | ||||||
Adjusted EBITDA Margin | (9 | )% | (7 | %) | 4 | % | 0 | % | ||||||||
Adjusted EBITDA Less Share-Based Compensation | $ | (3,289 | ) | $ | (2,836 | ) | $ | 668 | $ | (1,360 | ) |
___________________
(a) Represents litigation provision associated with certain litigation matters. We intend to appeal the judgment awarded in
(b) Represents non-cash compensation charges related to share-based compensation granted to our officers, employees and directors.
(c) Represents non-capitalizable costs of professional services primarily incurred in connection with our legal proceedings.
(d) Represents realized and unrealized foreign currency translation gains and losses primarily due to movement in the foreign currency exchange rates during the applicable periods.
(e) Represents certain expenses associated with consolidations of our tracer diagnostics business operations and Repeat Precision’s manufacturing operations in
(f) Represents the impact of a research and development subsidy that is included in income tax expense in accordance with GAAP along with other charges and credits.
FREE CASH FLOW AND FREE CASH FLOW LESS DISTRIBUTIONS TO NON-CONTROLLING INTEREST | ||||||||
Six Months Ended | ||||||||
2023 | 2022 | |||||||
Net cash used in operating activities | $ | (1,042 | ) | $ | (5,198 | ) | ||
Purchases of property and equipment | (1,151 | ) | (420 | ) | ||||
Purchase and development of software and technology | (167 | ) | (56 | ) | ||||
Proceeds from sales of property and equipment | 340 | 175 | ||||||
Free cash flow | $ | (2,020 | ) | $ | (5,499 | ) | ||
Distributions to non-controlling interest | — | — | ||||||
Free cash flow less distributions to non-controlling interest | $ | (2,020 | ) | $ | (5,499 | ) |
Source: NCS Multistage Holdings, Inc.